ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HALO Halozyme Therapeutics Incorporated

42.56
-1.28 (-2.92%)
11 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 117.28M152.37M208.98M181.5M162.14M221.04M216.03M230.04M
Operating Income 75.67M34.06M63.19M74.51M53.8M94.46M88.28M101.04M
Pre Tax Income 74.41M30.01M73.71M70.79M52.24M93.16M101.76M101.18M
Net Income 60.11M22.69M61.63M57.7M39.62M74.75M81.84M85.39M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 76.17M33.61M60.93M74.51M53.8M94.46M88.28M101.04M
EBITDA 76.45M46.61M92.4M81.62M74.26M115.09M111.36M121.73M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 146.69M316.61M151.86M195.99M267.59M443.31M660.12M829.25M
Operating Income -83.21M81M-69.33M-67.61M144.26M275.9M267.53M337.57M
Pre Tax Income -101.86M61.61M-79.79M-72.25M129.3M248.52M248.92M348.33M
Net Income -103.02M62.97M-80.33M-72.24M129.09M402.71M202.13M281.59M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.7480.417-0.525-0.4990.9012.7641.412.007
EBIT -83.21M81M-61.75M-60.62M149.68M254.94M264.82M337.57M
EBITDA -80.8M83.16M-66.94M-63.54M147.54M278.9M317.17M422.43M

Your Recent History

Delayed Upgrade Clock